Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2011 (2011), Article ID 154165, 3 pages
http://dx.doi.org/10.1155/2011/154165
Case Report

Bipolar Affective Disorder and Parkinson's Disease

Department of Neurology, Fachklinikum Brandis, Am Wald, 04821 Brandis, Germany

Received 13 August 2011; Accepted 19 October 2011

Academic Editor: Arya Mitra Sharma

Copyright © 2011 Birk Engmann. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Ulla, S. Thobois, J. J. Lemaire et al., “Manic behaviour induced by deep-brain stimulation in Parkinson's disease: evidence of substantia nigra implication?” Journal of Neurology, Neurosurgery and Psychiatry, vol. 77, no. 12, pp. 1363–1366, 2006. View at Publisher · View at Google Scholar · View at PubMed
  2. M. S. Keshavan, A. S. David, H. S. Narayanen, and P. Satish, “"On-off" phenomena and manic-depressive mood shifts: case report,” Journal of Clinical Psychiatry, vol. 47, no. 2, pp. 93–94, 1986. View at Google Scholar
  3. C. A. Zarate Jr., J. L. Payne, J. Singh et al., “Pramipexole for bipolar II depression: a placebo-controlled proof of concept study,” Biological Psychiatry, vol. 56, no. 1, pp. 54–60, 2004. View at Publisher · View at Google Scholar · View at PubMed
  4. E. Kim, A. S. Zwil, T. W. McAllister, D. S. Glosser, M. Stern, and H. Hurtig, “Treatment of organic bipolar mood disorders in Parkinson's disease,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 6, no. 2, pp. 181–184, 1994. View at Google Scholar
  5. S. Scappa, P. Teverbaugh, and J. Ananth, “Episodic tardive dyskinesia and parkinsonism in bipolar disorder patients,” Canadian Journal of Psychiatry, vol. 38, no. 10, pp. 633–634, 1993. View at Google Scholar
  6. F. K. Goodwin and K. R. Jamison, Manic-Depressive Illness, Oxford University Press, 2007.
  7. A. Kummer, F. M. V. Dias, F. Cardoso, and A. L. Teixeira, “Low frequency of bipolar disorder, dopamine dysregulation syndrome, and punding in Brazilian patients with Parkinson's disease,” Revista Brasileira de Psiquiatria, vol. 32, no. 1, pp. 62–65, 2010. View at Publisher · View at Google Scholar
  8. G. Kirov, K. C. Murphy, M. J. Arranz et al., “Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder,” Molecular Psychiatry, vol. 3, no. 4, pp. 342–345, 1998. View at Google Scholar
  9. A. Rousseva, C. Henry, D. van den Bulke et al., “Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism,” Pharmacogenomics Journal, vol. 3, no. 2, pp. 101–104, 2003. View at Publisher · View at Google Scholar · View at PubMed
  10. G. N. Papadimitriou, J. R. Calabrese, D. G. Dikeos, and G. N. Christodoulou, “Rapid cycling bipolar disorder: biology and pathogenesis,” International Journal of Neuropsychopharmacology, vol. 8, no. 2, pp. 281–292, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. G. Laux, “Possibilities and limitations of psychopharmacological treatments in patients with psychological comorbidity,” Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, vol. 54, no. 1, pp. 37–45, 2011. View at Publisher · View at Google Scholar · View at PubMed
  12. P. Barone, “Treatment of depressive symptoms in Parkinson's disease,” European Journal of Neurology, vol. 18, supplement 1, pp. 11–15, 2011. View at Publisher · View at Google Scholar · View at PubMed
  13. M. E. Thase, W. MacFadden, R. H. Weisler et al., “Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study),” Journal of Clinical Psychopharmacology, vol. 26, no. 6, pp. 600–609, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. G. M. Goodwin, “Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British association for psychopharmacology,” Journal of Psychopharmacology, vol. 23, no. 4, pp. 346–388, 2009. View at Publisher · View at Google Scholar · View at PubMed
  15. K. Gao, D. E. Kemp, S. J. Ganocy, P. Gajwani, G. Xia, and J. R. Calabrese, “Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review,” Journal of Clinical Psychopharmacology, vol. 28, no. 2, pp. 203–209, 2008. View at Publisher · View at Google Scholar · View at PubMed